ReNeuron Relocates to Wales with Funding
Arthurian Life Sciences Limited, manager of the Wales Life Sciences Investment Fund, has arranged a 12.8 million pounds ($19.6 million) funding commitment from the Welsh Government to enable ReNeuron to relocate to Wales and continue to grow the unique stem cell R&D, clinical trials and manufacturing base of the company. The funding package is made up of 5 million pounds direct equity investment from the Wales Life Sciences Investment Fund and a 7.8 million pounds commitment of non-dilutive grants from the Government.
22 July 2013•8 mins read
